Beyond the medicines we strive to discover and develop for patients with difficult to treat cancers, Cleave Biosciences supports patients by providing information about recruiting clinical trials, publications and patient advocacy organizations.
Information about our Phase 1 study evaluating CB-5083 in patients with relapsed/refractory multiple myeloma is available by visiting www.clinicaltrials.gov (ID# NCT02223598).
Information about our Phase 1 study evaluating CB-5083 in patients with advanced solid tumors is available by visiting www.clinicaltrials.gov (ID# NCT02243917).
The links below offer a wealth of additional resources, both in the U.S. and internationally.
Clinical Trial Information Resources
General Cancer Information Resources